20 21 Somatic mutations affecting the genes that encode core components of the splicing machinery, 34 first discovered in blood malignancies 1 , have now been observed in nearly every cancer type 2-4 . These 35 somatic mutations are largely present in factors including SF3B1, SRSF2, ZRSR2 and U2AF1, that are 36 involved in selection of branch-point, exonic sequences, and 3'-splice sites. Spliceosome mutations 37 result in hundreds of changes in alternative splicing, which vary among tissues and patients 5 . The 38 spectrum of mutations, the stoichiometry in tumors, and the clinical outcomes point toward splicing 39 factor mutations as oncogenic events 4 . However, there is little consensus on the molecular mechanism 40 of action in human carcinogenesis. 41
Abstract 22
Somatic mutations in the genes encoding components of the spliceosome occur frequently 23 in human neoplasms, including myeloid dysplasias and leukemias and less often in solid tumors. 24
One of the affected factors, U2AF1, is involved in splice site selection, and the most common 25 change, S34F, alters a conserved nucleic acid binding domain, recognition of the 3'-splice site, and 26 alternative splicing of many mRNAs. However, the role that this mutation plays in oncogenesis is 27 still unknown. Here, we have uncovered a non-canonical function of U2AF1, showing that it binds 28 mature mRNA in the cytoplasm and negatively regulates mRNA translation. This splicing-29 independent role of U2AF1 is altered by the S34F mutation, and polysomal profiling indicates the 30 mutation affects translation of hundreds of mRNA. One functional consequence is increased 31 synthesis of the secreted chemokine interleukin 8 which contributes to metastasis, inflammation, 32 and cancer progression in mice and humans. 33 changes observed in human tissue can be recapitulated in a Human Bronchial Epithelial Cell (HBEC) line 48 carrying the heterozygous U2AF1-S34F mutation 12 . However, mutant HBECs do not exhibit any visible 49 morphological or altered growth phenotypes 12 , indicating the mutation is not a strong driver mutation. 50
Although the S34F mutation mediates subtle splicing changes, these isoform shifts have not been 51 definitively linked to a phenotype, leading some investigators to propose nuclear RNA processing 52 defects such as alterations in 3' UTRs 20 or an increase in R-loops 21 . 53
Here, we show that U2AF1 functions as a translational repressor in the cytoplasm. U2AF1 54 interacts with hundreds of spliced, poly-adenylated mRNA in the cytoplasm, many of which are mTOR-55 regulated and code for proteins involved in translation initiation and growth. Through RIP-seq and 56 polysome profiling, we show that the cancer-associated S34F mutation results in loss of binding and 57 positive for the senescence marker b-galactosidase and remained in a senescent state in culture for > 30 82 days, whereas the wt/wt and wt/-mutant cells died 10-12 days post irradiation (Extended Data Fig. 1d ). 83
Thus, U2AF1 S34F provides resistance to clinically relevant doses of X-rays. 84
These results bear resemblance to the phenomenon of oncogene-induced senescence, where 85 non-proliferating cells contribute to oncogenesis through secretion of factors into the surrounding 86 tissue [22] [23] [24] [25] . We investigated if these cells secreted analytes characteristic of senescent cells, and tested 87 by ELISA for a panel of 10 cytokines or chemokines (IL1a, IL1b, IL2, IL4, IL6, IL8, IL10, IFNg & TNfa) in 88 media collected post irradiation over a 30-day period. Two cytokines -IL8 and IL1a -showed altered 89 secretion patterns. Strikingly, the senescent wt/S34F mutant cells exhibited sustained secretion of IL8 90 for over 30 days, and this phenotype could be rescued by frame-shifting the mutant allele ( Fig. 1b) . Even 91 at steady state (no irradiation), the wt/S34F mutant cells secreted elevated levels of IL8 compared to 92 wt/wt cells (17-fold increase), and this phenomenon was rescued in the wt/S34F-line ( Fig. 1c ). We 93 confirmed this observation in human lung cancer cell lines A549 and H441 and the myeloid leukemia cell 94 line NKM1 which were either gene-edited to create the S34F mutation or correct a naturally-occurring 95 U2AF1-S34F mutation: each cell line secreted elevated levels of IL8 in a mutant-dependent manner (Fig.  96 1c). In contrast, the wt/S34F HBEC cells showed decreased secretion of IL1a relative to wt/wt cells 97 before and after irradiation, an effect which was also rescued in wt/S34F-cells ( Fig. 1d ; Extended Data 98 Figure 1e ). In summary, U2AF1-S34F cells show radiation resistance and altered secretion of 99 inflammatory cytokines even before treatment with X-rays. Because of the role of inflammatory 100 cytokines in cancer 26, 27 , we chose to study this phenotype further. 101 U2AF1 is present in the cytoplasm and binds mature mRNA
102 Surprisingly, we observed no changes in IL8 splicing by RNA-seq 12 . Moreover, we did not observe 103 any significant change in IL8 expression between wt/wt and wt/S34F mutant cells as measured by single-104 molecule RNA-FISH and gene expression (RT-qPCR) analyses ( Fig. 2a & Extended Data Fig 2a) . Previous 105 studies have shown IL8 expression is regulated both at the level of mRNA stability and translational 106 control [28] [29] [30] . Since there was no change in IL8 mRNA levels, the elevated secretion of IL8 in wt/S34F cells 107 is controlled either at the level of translation or trafficking/secretion. We therefore sought to determine 108 if U2AF1 could be playing a role in regulation of this message independent of splicing. 109
We first asked whether U2AF1 interacts with IL8 mRNA. Fluorescently labeled U2AF1 has been 110 shown to shuttle between the nucleus and cytoplasm in plant cells 31 and using a heterokaryon assay in 111 human cells 32 . Also, splicing factors have been implicated in translational control [33] [34] [35] , leading us to ask 112 whether there exists a cytoplasmic population of U2AF1 in human cells. We observed localisation of 113 U2AF1 in the cytoplasm of wt/wt cells by immunostaining with ~30% localised in the cytoplasm (Fig. 2b) , 114 and we could immunoprecipitate U2AF1 from the cytoplasmic fraction with minimal nuclear 115 contamination ( Fig. 2c, Extended Data Fig. 2b & c) . We next tested for the presence of mature spliced, 116 poly-adenylated mRNA in the cytoplasmic U2AF1-immunoprecipitates and detected the presence of 117 mRNA for IL1a, IL8 and DNA pol H in substantial quantities, but very little of RPB3 mRNA (Fig. 2d , 118
Extended Data Fig 2d) , suggesting preferential binding of U2AF1 to certain mRNAs and not others. In the 119 wt/S34F mutant cells, binding of U2AF1 to IL8 mRNA was significantly lower ( Fig. 2d ; Extended Data Fig  120   2d ; note: wt/S34F cells are heterozygous and the antibody recognizes both wt and S34F forms of 121 U2AF1). 122
We next sought to generate a comprehensive transcriptome-wide view of U2AF1 interactions 123 with RNA in the cytoplasm. RNA-IP under native conditions was performed on cytosolic extracts with 124 anti-U2AF1 followed by sequencing (RIP-seq) of associated RNAs. Strikingly, we observed that mRNAs 125 whose translation is regulated by mTOR are highly enriched in the U2AF1 RIP in wt/wt cells ( Fig. 2e , blue 126 circles, Extended Data Table 2 ). In fact, in a rank ordered-list of RIP/input for all messages exceeding a 127 threshold for expression (1,117 transcripts, RPKM > 1 in all fractions and samples; Extended Data Table  128 3) some of the top hits are mTOR-regulated mRNA (RPS6, IPO7, NPM1, RPS19). Moreover, mTOR-129 A non-canonical function for U2AF1 as a translational repressor
142
The decreased binding of U2AF1 to IL8 mRNA in wt/S34F cells, coupled with increased levels of 143 IL8 in the media, led us to consider that U2AF1 might function as a translational repressor. To test this 144 hypothesis we performed polysome profiling. We isolated polysomes from wt/wt, wt/S34F and wt/S34F-145 mutant cells ( Fig. 3a, b ; Extended Data Fig 3a) and determined fractional amount of mRNA relative to 146 monosomes. mRNAs of sufficient length with high initiation rates contain multiple ribosomes 147 (polysomes) and appear in the heavy fractions of a sucrose gradient, while mRNAs with low initiation 148 rates appear in fractions containing small polysomes or 80s monosomes 42 . In addition to IL8 and IL1a, 149
we tested the mRNAs of NPM1 and PABPC1, two mTOR-regulated RNAs which were either enriched or 150 not enriched as measured by U2AF1 RIP-seq (Extended data Table 3 ). NPM1 and IL8 show loss of binding 151 in the wt/S34F cells and were enriched in the heavy polysome fractions (Fig. 3b ). PABPC1 mRNA shows 152 no change (Fig 3b) . The enhanced translational efficiency observed for NPM1 and IL8 mRNA by 153 polysome analysis in mutant cells was also reflected in the steady state protein levels ( Fig. 3c ). We also 154 tested steady state protein levels for several other genes: IPO7 (reduced binding in wt/S34F) and TSC2 155 (mTOR-sensitive but not detected above threshold in RIP) showed higher levels of protein; RUNX1 and 156 TRIM28 (no change or small gain in binding) showed no change or decreased translation respectively 157 ( Fig. 3c ). 158
We next sought to comprehensively test for a direct repressive role of U2AF1 in translation 159 which might be altered by the S34F mutation by sequencing the mRNA isolated from polysome fractions 160 (Extended Data Table 4 ). Individual polysome profiles are shown in Fig. 4a . NPM1, IL8, and IPO7 161 translational changes in wt/S34F cells were re-capitulated in the genome-wide assay, while PABPC1 162 showed no change in translational efficiency with mutation status. The cytoplasmic binding targets of 163 U2AF1 from RIP-seq were then rank-ordered by loss of binding which occurred in wt/S34F cells and 164 divided into deciles (n~ 112 transcripts/decile, Fig. 4b ). The average polysome profiles from the top and 165 bottom deciles demonstrate that the transcripts which showed the greatest change in binding (decile 1) 166 also showed a polysome profile which is characteristic of more efficient translation ( Fig. 4c ). In fact, 167 when looking at a single ratio of polysome to monosomes over all deciles, we observe a systematic 168 trend where loss of binding as measured by RIP results in an increase in polysome/monosme ratio, with 169 the top two deciles showing the most pronounced effect ( Fig. 4d , green). This effect is not observed in 170 wt/wt cells (gray) and is rescued in wt/S34F-cells (red) ( Fig. 4d ). Supporting this result, when transcripts 171 are rank ordered by enrichment in the U2AF1 RIP in wt/wt cells, there is a systematic trend toward less 172 binding resulting in greater translation ( Fig. 4e , f). Thus, in independent measurements of RIP-seq and 173
POLY-seq, U2AF1-bound transcripts show lower translation. 174
Loss of U2AF1 binding in wt/S34F cells is predictive of gain in translation efficiency on hundreds 175 of messages, suggesting a functional role for U2AF1 in translational repression which is abrogated by the 176 S34F mutation. The targets of this translational repression pathway in wt/wt cells are enriched in 177 messages which themselves code for translation machinery (Fig. 2h ). However, the most substantial 178 changes in binding and translation with the S34F mutation occur for a subset of the translational 179 machinery, in the GO category of 'intracellular protein transport' (Extended Data Fig. 4 ). 180 U2AF1 regulates translation of IL8 via its 5'-UTR 181 Because we identified a role for U2AF1 in translation repression, we analyzed 5' UTRs for the 182 enrichment of the U2AF1 motif and found it to be pervasive, with 4608 out of 6441 experimentally 183 determined 5' UTRs containing the motif (FIMO, p<0.01). We also identified a number of 3'-ss like 184 sequences in the IL8 5' UTR. To test whether these motifs could be functioning as cis-acting U2AF1 185 binding sites, we made a series of IL8-T2A-GFP reporters ( Fig. 5a ) either with the wildtype 5'-UTR of IL8 186 or single point mutant in 3'-ss like sequences. This reporter contains no introns, and the GFP is not 187 secreted, thereby testing the translational control mechanism in a splicing-and secretion-independent 188 manner. We found that a point mutant in the canonical 3'-ss nearest the 5' end (changing the 189 trinucleotide sequence from "CAG" to "CAT") showed translation de-repression. Wt/wt and wt/S34F 190 mutant cells carrying either the wild type or mutant IL8 reporter had similar levels of RNA expression 191 ( Fig 5b) , and FACS analysis revealed that the wt/S34F mutant cells showed an increase (~1.4 fold) in the 192 fraction of the cells expressing GFP ( Fig. 3c ). Strikingly, we observed a 5-or 10-fold increase for the 5' UTR mutant IL8 194 reporter in cells that were either wild type or S34F mutant for U2AF1 respectively ( Fig. 5c-e ), indicating 195 that a point mutation in the U2AF1 motif in the IL8 5'-UTR was sufficient to overcome translational 196 repression. Similarly, the mutated 5'-UTR significantly compromised U2AF1 binding in both wt/wt and 197 wt/S34F cells ( Fig. 5f ). 198
Overall, our data indicate that U2AF1 represses translation in the cytosol, that this repression is 199 relieved in the presence of the S34F mutation on hundreds of messages, and that repression is mediated 200 for IL8 by a cis-acting sequence in the 5' UTR. 201
Elevated IL8 is associated with multiple measures of cancer progression 202 We next asked whether this change in IL8 translation was sufficient to mediate phenotypic 203 consequences. We carried out experiments on epithelial to mesenchymal transition (EMT), 204 inflammatory response, and tumor burden during cancer progression. EMT is a critical step in 205 metastasis 43-47 , known to be induced by IL8 43-45 , and is characterized by the induction of fibronectin and 206
repression of E-Cadherin expression in epithelial cells 46, 47 . Purified recombinant IL8 by itself elicited EMT 207 in MCF-7 cells ( Fig. 6a, b ), as determined from the emergence of a fibronectin-high and E-cadherin-low 208 population in tissue culture, as observed previously. Conditioned media from the wt/S34F mutant cells 209 also induced the expression of fibronectin and repression of E-cadherin, but the conditioned media from 210 wt/wt cells did not ( Fig. 6a, b ). These data indicate that the media from wt/S34F cells was biologically 211 active and was sufficient to induce EMT-related gene expression changes. 212
We then examined the role of the U2AF1-S34F mutation using xenografts. We used two 213 different human lung cancer lines (HCC78 and H441) with naturally occurring S34F mutations isolated 214 from patients and generated derived lines with frame-shifted mutant alleles as previously reported 12 . 215 H441 cells with or without S34F mutation were able to form subcutaneous xenograft tumors in athymic 216 nude mice with no apparent differences in tumor sizes, while HCC78-derived cells were unable to 217 establish tumor growth over a period of 150 days 12 . Presentation of inflammatory cells at the periphery 218 or inside the xenograft tumors (from H441) cells or residue cells (from HCC78 cells) were scored. In both 219 cases, the occurrence of the tumor-induced inflammation was reduced by removing the S34F mutant 220 copy from the human cell lines ( Fig. 6c ). 221
Next, we sought to assess the specific role of IL8 in mediating the ability of H441 cancer cells to 222 form tumors in mice. One caveat in these studies is that IL8 is not present in rodents, but homologs of 223 the IL8 receptors (CXCR1, CXCR2) are present. NOG mice were injected with H441 cells via tail vein and 224 were treated with neutralizing IL8 antibody or with an isotype-matched IgG three times a week for ten 225 weeks. Serum IL8 levels and tumor burden were then assessed after the mice were sacrificed three days 226 after the last antibody injection. Half of the mice (n=3) were given intraperitoneal injections of the anti-227 IL8 neutralizing antibody, and the other half were injected with the control IgG. Tumors were observed 228 in the liver, but predominantly in the lung (Fig. 6D , Extended Data Fig. 6 ). Although lung tumor burden 229 did not change (Extended Data Fig. 6 ), the tumor burden in the liver showed a significant decrease with 230 a corresponding decrease in serum levels of IL8 ( Fig. 6D) . Taken together, studies in tissue culture and 231 xenograft models demonstrate that EMT, immune infiltration, and tumor burden are sensitive to the 232 U2AF1 mutational status, and these effects are consistent with and/or mediated by changes in IL8. 233
Finally, we asked whether IL8 is elevated in relapsed/refractory acute myeloid leukemia (RR-234 AML), where spliceosome mutations are common 48 . We isolated serum from 24 RR-AML patients and 20 235 age-matched healthy donors. A third of the AML patients had known spliceosome mutations (U2AF1, 236 n=3; SRSF2, n=3; and SF3B1, n=2). Levels of 12 cytokines/growth factors were quantified using a 237 Luminex assay (Extended Table 5 ). Principal component analysis 49 revealed that 96% of the variation in 238 samples could be accounted for by two factors: VEGF and IL8 ( Fig. 6e ). Healthy individuals showed high 239 VEGF and low IL8 levels, while the RR-AML patients showed low VEGF and high IL8 levels ( Fig. 6f ). IL8 240 alone is significantly elevated in RR-AML patients compared to healthy donors (p=0.017, Fig. 6g ), and the 241 ratio of IL8/VEGF allowes superior discrimination (p=0.0007). On this 'axis' of IL8/VEGF, U2AF1 242 mutations cluster at an intermediate point, where VEGF is decreasing and IL8 is increasing ( Fig. 6f ). Thus, 243 U2AF1 S34F is not associated with the highest levels of IL8 in human AML but may function in a general 244 pathway whereby IL8 begins to condition the niche which supports proliferation of leukemic blasts. 245
Discussion

246
Here we show that U2AF1 can function in a non-canonical role as a translational repressor in the 247 cytosol. This pathway was revealed by the somatic S34F mutation which occurs in cancer, resulting in 248 translational de-repression of hundreds of mRNA, one of which (IL8) directly contributes to the 249 oncogenic phenotype. A simple explanation for the repressive effect is that U2AF1 binds mRNA and 250 stabilizes a translationally repressive state. In the presence of the S34F mutant, this repression is 251 partially relieved either by direct competition, or because the mutant selectively binds mRNA to stabilize 252 a translationally permissive state, resulting in lower overall binding of the U2AF1 protein. Importantly, 253 all of the phenotypes we report are rescued by frameshifting the mutant allele, arguing for a gain of 254 function dominant negative effect rather than simple loss of function. 255 U2AF1 selectively targets transcripts which code for the translation machinery, and the transcripts that 256
show the greatest de-repression in the presence of the S34F mutation are involved in protein transport. 257
Thus, there is the potential for both direct and indirect changes to the proteome. In fact, the substantial 258 change we see in extracellular IL8 may be due both to direct changes due to decreased U2AF1 binding 259 and also changes in translation, processing, and trafficking of mature IL8 which are indirect effects. 260
Translation initiation is often mis-regulated in cancer 50 and the translation machinery is tightly 261 controlled at the post-transcriptional level through the mTOR pathway, which is responsive to an array 262 of environmental conditions 51 . The oncogenic phenotypes we report here are sustained viability in the 263 presence of extreme genotoxic stress (20 Gy X-rays) or cell non-autonomous effects such as enhanced 264
EMT and immune infiltration mediated by elevated IL8 levels even in the absence of stress. Since IL8 265 contributes to recruitment of myeloid cells which suppress an adaptive immune response, one 266 prediction from this latter effect is that cells with splicing factor mutations will be refractory to 267 immunotherapy unless treated with neutralizing IL8 antibody. However, we speculate that the 268 U2AF1 S34F mutation could function in a cell-autonomous, pro-growth manner in tissue through this 269 mechanism of translational mis-regulation. 270
Materials and Methods
271
Plasmids, cell lines and cell cultures:
The plasmid expressing the IL8-2A-GFP reporters were constructed 272 by inserting a synthetic DNA fragment coding for wt or mutant IL8-2A-GFP between NotI and SphI sites 273 of a lentiviral packaging vector. Transcription from this reporter is driven off an Ubiquitin promoter. 274
Construction of WT, S34F and frameshift HBEC lines has been described previously 12 . To generate 275 reporter cell lines, WT or S34F mutant HBEC lines 12 were transduced with different titers of lentivirus 276 packaged with either WT or mt 5'-UTR IL8-2A-GFP reporter constructs. Reporter RNA expression was 277 measured by smFISH using fluorescently labeled probes (Biosearch Technologies, San Francisco, CA) 278 against GFP and cell populations with similar RNA levels were selected and expanded for further use. All 279 HBEC lines were cultured in Keratinocyte Serum Free Media supplemented with bovine pituitary extract 280 and EGF as prescribed by the manufacturer (Invitrogen, Carlsbad, CA) at 37 o C and 5% CO2. 281 282 Irradiation and WST-1 assay: WT or S34F mutant cells (1 X 10^4/well) were plated in 96 well plates and 283 grown for 24hrs before irradiation with x-rays (20Gy) (X-Rad 320, Precision X-Ray, North Branford, CT) 284 and cultured for 6 days post irradiation. Cell viability was measured at indicated times using the WST-1 285 (ROCHE/SIGMA, St Louis, MO) assay measuring the conversion of tetrazolium salts to formazan by 286 cellular tetrazolium reductase as per manufacturer's instructions for 1hr at 37 o C and 5% CO2. 287 288 ELISA: HBECs were plated (1 X 10^6/well) in a 6 well plate and irradiated with 20Gy of X-rays. At indicated 289 times, media was collected, filtered for cell debris using a 0.22 mm filter and snap frozen until ELISA was 290 performed. ELISA was performed in duplicate for each sample using Quansys Human Cytokine-291 Inflammation 9-plex kit (Quansys Biosciences, Logan, UT) containing IL1a, IL1 b, IL2, IL4, IL6, IL8, IL10, 292 IFN g & TNfa. The cytokine and chemokine levels were determined from the standard curve developed 293 with each experiment using standards provided by the manufacturer. The anylate levels (pg/mL) are the 294 mean of three independent experiments with standard deviation. 295
296
Immunofluorescence assay, image acquisition and analysis: Cells were seeded at ~30% confluency on 297 1.5mm thick round cover glass in 12 well plates and cultured under normal growth conditions (5% CO2, 298 
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c. ELISA of steady state secretion of IL8 into media collected after 6 days in culture of HBEC (wt/wt, wt/S34F, wt/-607 and wt/S34F-, (wt/wt vs wt/S34F p = 0.0003; wt/wt vs wt/S34F-p = 0.8533), human lung tumor cells (H441 and 608 A549, H441 S34F vs H441 S34Fp = 0.0614; A549 S34F vs A549 S34Fp = 0.0281) and human myeloid leukemia cell line 609 (NKM1, NKM1 S34F vs NKM1 S34Fp = 0.0251) and with their respective S34F mutant allele knockout cell lines 
752
FACS of wt/wt or wt/S34F cells expressing wt-or mt-5'-UTR IL8-2A-GFP reporter. wt/wt cells served as control for 753 autofluorescence and the wt/wt and wt/S34F cells expressing the wt-or mt-IL8-GFP reporter were gated above the 754 auto fluorescence from wt/wt control cells.
Figure 1. U2AF1 S34F mutant cells show altered cell viability and inflammatory cytokine secretion after DNA damage.
a. Altered growth in wt/wt, wt/S34F, wt/-and wt/S34F-mutant cells after irradiation with x-rays (20 Gy) measured using a cell proliferation assay at indicated times (average of 3 independent experiments +/-s.d.). b.Cytokine levels measured by ELISA in media collected at indicated times from wt/wt, wt/S34F, wt/-and wt/S34F-mutant cells after irradiation with x-rays (20 Gy). IL8 secreted into media is presented as pg/mL (average of 3 independent experiments +/-s.d.). c. ELISA of steady state secretion of IL8 into media collected after 6 days in culture of HBEC (wt/wt, wt/S34F, wt/-and wt/S34F-, (wt/wt vs wt/S34F p = 0.0003; wt/wt vs wt/S34F-p = 0.8533), human lung tumor cells (H441 and A549, H441 S34F vs H441 S34Fp = 0.0614; A549 S34F vs A549 S34Fp = 0.0281) and human myeloid leukemia cell line (NKM1, NKM1 S34F vs NKM1 S34Fp = 0.0251) and with their respective S34F mutant allele knockout cell lines (average of 3 biological replicates +/-s.d.). d. ELISA of steady state secretion of IL1-a into media collected after 6 days in culture of wt/wt, wt/S34F, wt/-and wt/S34Fmutant cells (average of 3 biological replicates +/-s.d. wt/wt vs wt/S34F p = 0.3446; wt/wt vs wt/S34F-p = 0.6601). P values determined by two sided T.test. The targets of this translational repression pathway are enriched in messages which themselves code for translation machinery, potentially resulting in direct and indirect changes in translation. EIF4Aregulated messages show increased translation in wt/S34F cells, despite not being direct binding targets. This result, however, is consistent with the change in EIF4A2 translation (Extended Data Table 3, 4). a. Average polysome profile from EIF4A-sensitive transcripts (Extended Data Table 2): polysome profiles from wt/wt (black), wt/S34F (green) and wt/S34F-(red). n=69 transcripts; bootstrap error. b. Average polysoome profile from mTOR-sensitive transcripts (Extended Data Table 2): polysome profiles from wt/wt (black), wt/S34F (green) and wt/S34F-(red). n=77 transcripts; bootstrap error. c. Polysome/monosome ratio for several different groups of transcripts. Each group contains three boxes reflecting the distribution of polysome/monosome ratios (from left to right): wt/wt, wt/S34F, wt/S34F-. The transcript groups, from left to right, are: decile 1 of changes in RIP/input from wt/wt to wt/S34F, decile 10, mTOR-sensitive transcripts, and EIF4A-sensitive transcripts. ** = p<0.001. * = p<0.05. d. mRNA length distribution within the D RIP deciles. There is no systematic difference in binding efficiency based on transcript length. e. GO terms for transcripts in decile 1 of changes in RIP/input from wt/wt to wt/S34F. FACS of wt/wt or wt/S34F cells expressing wt-or mt-5'-UTR IL8-2A-GFP reporter. wt/wt cells served as control for autofluorescence and the wt/wt and wt/S34F cells expressing the wt-or mt-IL8-GFP reporter were gated above the auto fluorescence from wt/wt control cells. Serum IL8 levels (gray bar) and the number of macroscopic lung nodules (black circles) from NOG mice injected (tail vein) with H441 isogenic cells, and treated with either isotype control or anti-IL8 antibodies for 10 weeks (n = 3 for each treatment group) . 
